Filing Details

Accession Number:
0001127602-18-001398
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-08 17:07:54
Reporting Period:
2018-01-05
Accepted Time:
2018-01-08 17:07:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610035 Hooman Hakami 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Evp & Group President Diabetes No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-01-05 26,158 $62.76 91,986 No 4 M Direct
Ordinary Shares Disposition 2018-01-05 26,158 $85.00 65,828 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2018-01-05 26,158 $0.00 26,158 $62.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,159 2024-07-28 No 4 M Direct
Footnotes
  1. This balance increased by 356 shares due to exempt transactions such as dividend reinvestment.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  4. This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  5. This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.